The CDC has updated its website to show two measles deaths in the U.S. this year. That means the agency is still out of step ...
Kratom has skirted regulation for decades, but newer, highly concentrated 7-OH products have renewed interest in safeguards.
The surest way to secure our biotech lead is to build up our own capabilities,” write Gary Locke and Patrick McHenry.
New research involving giving mice a human cell-based cortex brings to mind “Flowers for Algernon” and “Pinky and the Brain,” ...
Federal officials and health care executives rubbed elbows at the ritzy MAHA Summit, causing some supporters to question what ...
Some lawmakers are urging the Trump administration to rethink a pending rule that may prevent Americans from obtaining ...
The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to ...
A new study in mice led by Washington University in St. Louis researchers suggests that stopping certain immune cells from ...
At a MAHA Institute event, Kennedy and others argued that health data should be more accessible to researchers can study ...
Senate’s health committee doesn’t have a vote scheduled on the nominee to run the FDA.
UniQure's gene therapy continues to slow Huntington's progression after four years. But the magnitude of the benefit waned ...
Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results